Mecwins is delighted to announce that the China Patent Office has granted a new patent for an innovative method of digitally counting nanoparticles. The patent, entitled “Method for optically detecting biomarkers” (Patent CN111812013), marks a significant advancement in biosensor technology.
This newly patented method provides a state-of-the-art solution for detecting biomarkers by capturing and analyzing spatially and spectrally resolved images, reducing noise through data correction, and using statistical models to classify and count particles. It represents a major breakthrough in the digital counting of protein biomarkers.
The approval of this patent reinforces Mecwin’s commitment to driving innovation and excellence in nanotechnology and biosensing. This achievement further enhances our intellectual property portfolio and strengthens our position as a key player in the development of cutting-edge technological solutions for healthcare.
